Australian biotech market watch 13/01/10
13 January, 2010 by Tim DeanChemGenex, Ramsay Health Care, Mesoblast, Biota, Sonic Health Care, CSL
Secrets of duck sex: it's all screwed up
24 December, 2009 by Staff WritersFemale ducks found to have evolved a counter mechanism to males with corkscrew-shaped penises.
Feature: Root of the matter
23 December, 2009 by Graeme O'NeillWith the world’s phosphate reserves rapidly running out, Professor Hans Lambers suggests crop breeders and agronomists take a close look at nature’s solutions to the problem.
Ancient koalas had booming voices
21 December, 2009 by Staff WritersA study of the ancestors to modern koalas shows they had a different diet but could produce 'bellowing' calls.
New R&D tax credit draft legislation released
21 December, 2009 by Tim DeanSubmissions open before legislation introduced to parliament in 2010.
Australian biotech market watch 17/12/09
17 December, 2009 by Tim DeanPrima BioMed, Patrys, Living Cell Technology, Blackmores, Cochlear, ResMed
Biotron anti-viral effective against HIV
17 December, 2009 by Staff WritersResults announced at HIV conference show BIT225 stops virus spreading.
Invetech helps bring bio-printers to life
11 December, 2009 by Staff WritersAustralian R&D firm delivers first of 3D bio-printer to Organovo using latter's NovoGen technology.
Clinuvel gets positive results for afamelanotide
10 December, 2009 by Tim DeanPilot study shows afamelanotide improves quality of life in cancer patients.
Australian biotech market watch 08/12/09
08 December, 2009 by Tim DeanCLS, Cochlear, ResMed, Ansell, Living Cell Technology, Ramsay Health Care, ChemGenex
Feature: Plumbing the peptides of spider toxins
03 December, 2009 by Graeme O'NeillFrench toxinologist, Pierre Escoubas, is finding interesting pharmacology in the venoms of smaller species that punch way above their weight.
Biotech Market Spotlight: Sonic Healthcare
02 December, 2009 by Tim DeanSonic Healthcare (ASX:SHL) continues its expansion strategy in the U.S.
QRxPharma kicks off pivotal trial for MoxDuo
02 December, 2009 by Tim DeanPhase III trial for MoxDuo IR in the U.S. with final trial to begin in 2010.
Feature: Microscopy in the third dimension
01 December, 2009 by Fiona WylieDr Nicole Bryce is applying her experience in 3-D imaging to see just how far fluorescent drugs can penetrate into live tumour-cell masses.
Australian biotech market watch 25/11/09
25 November, 2009 by Tim DeanPrima BioMed, QRxPHarma, Sirtex Medical, Primary Health Care, ResMed, Cochlear
